Kancera AB (publ) (ST:KAN) — Stock Price

Skr0.15 SEK
▼ -23.82% today

Kancera AB (publ) (ST:KAN) is currently trading at Skr0.15 SEK, down 23.82% today. Over the past 52 weeks, shares have ranged between Skr0.15 and Skr0.99. This page tracks Kancera AB (publ)'s live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Kancera AB (publ).

Kancera AB (publ) (KAN) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Kancera AB (publ)'s daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Kancera AB (publ) Income Statement — Revenue, Profit & Earnings by Year

Kancera AB (publ)'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue Skr14.00K Skr1.03 Million Skr753.00K Skr1.70 Million Skr90.00K
Cost of Revenue Skr0.00 Skr3.00 Million Skr360.00K Skr320.00K Skr27.00K
Gross Profit Skr14.00K Skr1.03 Million Skr393.00K Skr1.38 Million Skr63.00K
Research & Development Skr39.95 Million Skr57.99 Million Skr45.61 Million Skr42.63 Million Skr39.28 Million
SG&A Skr5.15 Million Skr6.35 Million Skr4.68 Million Skr3.62 Million Skr11.66 Million
Total Operating Expenses Skr46.17 Million Skr66.08 Million Skr52.69 Million Skr46.96 Million Skr50.18 Million
Operating Income Skr-46.16 Million Skr-65.04 Million Skr-51.93 Million Skr-45.26 Million Skr-51.81 Million
EBITDA Skr-43.16 Million Skr-62.04 Million Skr-52.01 Million Skr-45.35 Million Skr-44.76 Million
EBIT Skr-46.16 Million Skr-65.04 Million Skr-52.37 Million Skr-45.67 Million Skr-46.46 Million
Interest Expense Skr373.00K Skr118.00K Skr17.00K Skr1.10 Million
Income Before Tax Skr-44.57 Million Skr-64.89 Million Skr-52.48 Million Skr-45.69 Million Skr-47.56 Million
Income Tax Expense Skr-1.00 Skr-432.00K Skr-413.00K Skr-2.54 Million
Net Income Skr-44.57 Million Skr-64.89 Million Skr-52.48 Million Skr-45.69 Million Skr-40.50 Million

Kancera AB (publ) Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Kancera AB (publ)'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets Skr66.91 Million Skr65.64 Million Skr120.74 Million Skr133.41 Million Skr83.10 Million
Total Current Assets Skr48.91 Million Skr47.64 Million Skr99.49 Million Skr112.03 Million Skr61.17 Million
Cash & Equivalents Skr46.36 Million Skr45.69 Million Skr95.15 Million Skr106.52 Million Skr55.01 Million
Short-term Investments
Net Receivables Skr2.00 Million Skr1.24 Million Skr3.33 Million Skr3.46 Million Skr5.88 Million
Inventory Skr-1.24 Million Skr-4.34K Skr234.00K Skr-6.17K
Property, Plant & Equipment Skr0.00 Skr247.00K Skr607.00K Skr927.00K
Goodwill
Total Liabilities Skr4.61 Million Skr17.98 Million Skr13.83 Million Skr10.87 Million Skr10.82 Million
Total Current Liabilities Skr4.61 Million Skr17.98 Million Skr13.83 Million Skr10.43 Million Skr9.84 Million
Long-term Debt Skr0.00 Skr0.00 Skr0.00 Skr0.00 Skr448.00K
Net Debt Skr-46.36 Million Skr-45.69 Million Skr-95.15 Million Skr-105.95 Million Skr-53.69 Million
Total Stockholder Equity Skr62.30 Million Skr47.66 Million Skr106.91 Million Skr122.54 Million Skr72.28 Million
Retained Earnings Skr-44.57 Million Skr-365.83 Million Skr-360.94 Million Skr-308.46 Million Skr-47.56 Million

Kancera AB (publ) Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Kancera AB (publ) generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow Skr-58.53 Million Skr-55.67 Million Skr-47.56 Million Skr-44.12 Million Skr-46.05 Million
Capital Expenditures Skr0.00 Skr0.00 Skr0.00 Skr0.00 Skr0.00
Free Cash Flow Skr-58.53 Million Skr-55.67 Million Skr-47.56 Million Skr-44.12 Million Skr-46.05 Million
Investing Cash Flow Skr0.00 Skr0.00 Skr0.00 Skr0.00
Financing Cash Flow Skr59.20 Million Skr6.21 Million Skr36.19 Million Skr95.64 Million Skr82.15 Million
Dividends Paid
Stock-Based Compensation
Depreciation Skr0.00 Skr3.00 Million Skr360.00K Skr320.00K Skr1.70 Million
Change in Cash Skr670.00K Skr-49.46 Million Skr-11.37 Million Skr51.51 Million Skr43.16 Million

Kancera AB (publ) Earnings History — EPS Actual vs. Analyst Estimates

Track Kancera AB (publ)'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 21, 2026
Feb 19, 2026
Nov 21, 2025
Aug 22, 2025 -0.05
May 23, 2025 -0.11
Feb 21, 2025 -0.08
Nov 15, 2024 -0.09
Aug 23, 2024 -0.09 -0.17 +47.06%